Association between Lysyl oxidase G473A polymorphism and ovarian cancer in the han Chinese population

Journal of International Medical Research

Volumn 40, Issue 3, 2012, Pages 917-923

  Wang, X ^a   Cong, J L ^a   Qu, L Y ^a   Jiang, L ^a   Wang, Yan ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Clinicopathological characteristics; Lysyl oxidase; Metastasis; Ovarian cancer; Single nucleotide Polymorphism

Indexed keywords

PROTEIN LYSINE 6 OXIDASE;

ADULT; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LOX GENE; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84863107207     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000310     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Hall M, Rustin G: Recurrent ovarian cancer: when and how to treat. Curr Oncol Rep 2011; 13: 459-471.
3. Russo A, Calò V, Bruno L, et al: Hereditary ovarian cancer. Crit Rev Oncol Hematol 2009; 69: 28-44.
4. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
5. Fasching PA, Gayther S, Pearce L, et al: Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol 2009; 3: 171-181.
6. Roy R, Chun J, Powell SN: BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 2011; 12: 68-78.
7. Lucero HA, Kagan HM: Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci 2006; 63: 2304-2316.
8. Kaneda A, Wakazono K, Tsukamoto T, et al: Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 2004; 64: 6410-6415.
9. Papachroni KK, Piperi C, Levidou G, et al: Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue. J Cell Mol Med 2010; 14: 2460-2469.
10. Papacleovoulou G, Critchley HO, Hillier SG, et al: IL1::and IL4 signalling in human ovarian surface epithelial cells. J Endocrinol 2011; 211: 273-283.
11. Nishioka T, Eustace A, West C: Lysyl oxidase: from basic science to future cancer treatment. Cell Struct Funct 2012; 37: 75-80.
12. Erler JT, Giaccia AJ: Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res 2006; 66: 10238-10241.
13. Min C, Yu Z, Kirsch KH, et al: A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res 2009; 69: 6685-6693.
14. Ren J, Wu X, He W, et al: Lysyl oxidase 473 G>A polymorphism and breast cancer susceptibility in Chinese Han population. DNA Cell Biol 2011; 30: 111-116.
15. Odicino F, Pecorelli S, Zigliani L, et al: History of the FIGO cancer staging system. Int J Gynecol Obstet 2008; 101: 205-210.
16. Albinger-Hegyi A, Stoeckli SJ, Schmid S, et al: Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). Int J Cancer 2010; 126: 2653-2662.
17. Allen M, Jones JL: Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 2011; 223: 162-176.
18. Csiszar K: Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 2001; 70: 1-32.
19. Wilgus ML, Borczuk AC, Stoopler M, et al: Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer 2011; 117: 2186-2191.
20. Min C, Zhao Y, Romagnoli M, et al: Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis. J Cell Biochem 2010; 111: 1160-1168.
21. Wu M, Min C, Wang X, et al: Repression of BCL2 by the tumor supressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res 2007; 67: 6278-6285.
22. Palamakumbura AH, Vora SR, Nugent MA, et al: Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene 2009; 28: 3390-3400.